Question to the Department of Health and Social Care:

To ask His Majesty's Government what further steps they plan to take to safeguard a reliable supply of radioisotopes for use in the NHS.

The resilience of United Kingdom supply chains is a key priority, and the Department and NHS England are committed to helping to build long term supply chain resilience for medicines. We recognise the importance of ensuring a resilient and reliable supply of medical isotopes and how important that is for patients and for the National Health Service. We regularly engage with industry partners to support continued supply of medical radioisotopes to the NHS, including responding to supply disruptions. The Department is working with the NHS and other parts of the Government to better understand future needs for medical radioisotopes.

In respect to isotope production and associated research in the UK, the Government has made up to £520 million available through the Life Sciences Innovative Manufacturing Fund to support UK manufacture of medicine and medical technology products. This includes applications looking to establish, expand, or improve UK-based manufacture of medical radioisotopes for diagnostic or therapeutic applications. In addition, last year, the Government also announced a £54 million funding package for eight innovative research and development projects, including £9.9 million earmarked for Project Alpha to explore how to make medical treatments from legacy nuclear material, something that could unlock the UK’s potential to develop promising new cancer therapies.